Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Current Diabetes Reports
Published in: Current Diabetes Reports 10/2017

01-10-2017 | Microvascular Complications—Retinopathy (JK Sun and PS Silva, Section Editors)

Intraocular Inflammation in Diabetic Populations

Authors: Wajiha J. Kheir, Huda A. Sheheitli, Rola N. Hamam

Published in: Current Diabetes Reports | Issue 10/2017

Login to get access

Abstract

Purpose of review

The purpose of this review is to determine the prevalence of uveitis in the diabetic population, the clinical features of the uveitis and diabetes when coexisting and pathophysiology of a possible correlation. We also aim to review the cases of diabetes and uveitis in the literature.

Recent findings

The basis of an association between uveitis and diabetes mellitus (DM) is the common pathophysiology of inflammation. There are several reports on a DM-related uveitis, defined as idiopathic anterior uveitis in the presence of poorly controlled DM, but causation has not been established.

Summary

There are conflicting results in the literature regarding an association between uveitis and DM. More studies are needed to determine if an association truly exists.
Literature
1.
Castagna I, Fama F, Salmeri G. Anterior uveitis and diabetes mellitus: immunological study. Ophthalmologica. 1995;209(2):53–5.CrossRefPubMed
2.
Herranz M, et al. Increased prevalence of NIDDM in anterior uveitis. Diabetes Care. 1997;20(11):1797.CrossRefPubMed
3.
Oswal KS, et al. Clinical features of patients with diabetes mellitus presenting with their first episode of uveitis. Ocul Immunol Inflamm. 2009;17(6):390–3.CrossRefPubMed
4.
Al-Halafi A, et al. The association of systemic disorders with Vogt-Koyanagi-Harada and sympathetic ophthalmia. Graefes Arch Clin Exp Ophthalmol. 2011;249(8):1229–33.CrossRefPubMed
5.
Waite JH, Beetham WP. The visual mechanism in diabetes mellitus: a comparative study of 2002 diabetics, and 457 non-diabetics for control. N Engl J Med. 1935;212(9):367–79.CrossRef
6.
7.
8.
Ojaimi E, et al. Vogt-Koyanagi-Harada disease, diabetes mellitus, and psoriasis in a child. Ocul Immunol Inflamm. 2012;20(1):56–8.CrossRefPubMed
9.
Rottgers E, Holdeman NR. An unusual case of chorioretinitis in a diabetic patient. Clin Exp Optom. 2009;92(2):142–5.CrossRefPubMed
10.
Sinha MK, Narayanan R, Chhablani JK. Hypopyon uveitis following panretinal photocoagulation in a diabetic patient. Semin Ophthalmol. 2014;29(3):166–8.CrossRefPubMed
11.
Takahashi Y, et al. Severe anterior uveitis associated with idiopathic dacryoadenitis in diabetes mellitus patient. Clin Ophthalmol. 2011;5:619–21.PubMedPubMedCentral
12.
• Tyagi M, Ambiya V, Rani PK. Hypopyon uveitis following panretinal photocoagulation. BMJ Case Rep. 2016; This case report is of a patient with DM and uveitis who develops recurrent ocular inflammation after panretinal photoagulation
13.
Stanga P, Boyd S, Hamilton A. Ocular manifestations of diabetes mellitus. Curr Opin Ophthalmol. 1999;10(6):483–9.CrossRefPubMed
14.
Liberman P, et al. Causes of uveitis in a tertiary center in Chile: a cross-sectional retrospective review. Ocul Immunol Inflamm. 2014:1–7.
15.
16.
•• Oswal KS, et al. Clinical course and visual outcome in patients with diabetes mellitus and uveitis. BMC research notes. 2013;6(1):167. This retrospective study reported a greater complication rate, reduced vision and poor glycemic control in patients with DM who develop uveitis CrossRefPubMedPubMedCentral
17.
Chatzistefanou K, et al. Characteristics of uveitis presenting for the first time in the elderly. Ophthalmology. 1998;105(2):347–52.CrossRefPubMed
18.
19.
Barton K, et al. Uveitis presenting de novo in the elderly. Eye (Lond). 1994;8(Pt 3):288–91.CrossRef
20.
Nalcacioglu-Yuksekkaya P, et al. Clinical and demographic characteristics of patients with uveitis starting later in life. Ocul Immunol Inflamm. 2014:1–7.
21.
Martyn C, Young R, Ewing D. Is there a link between iritis and diabetic autonomic neuropathy? Br Med J (Clin Res Ed). 1986;292(6525):934.CrossRef
22.
Gregoire MA, et al. Characteristics of uveitis presenting for the first time in the elderly: analysis of 91 patients in a tertiary center. Ocul Immunol Inflamm. 2011;19(4):219–26.CrossRefPubMed
23.
Hemidan A, Tabbara K, Althomali T. Vogt-Koyanagi-Harada associated with diabetes mellitus and celiac disease in a 3-year-old girl. Eur J Ophthalmol. 2006;16(1):173.PubMed
24.
Jaggarao N, Voth D, Jacobsen J. The Vogt-Koyanagi-Harada syndrome: association with hypothyroidism and diabetes mellitus. Postgrad Med J. 1989;65(766):587–8.CrossRefPubMedPubMedCentral
25.
Maruyama Y, et al. A case of insulin dependent diabetes mellitus following systemic treatment with corticosteroids for Vogt-Koyanagi-Harada syndrome. Ophthalmic Surgery, Lasers and Imaging Retina. 2000;31(6):487–90.
26.
Murray D, Sung V, Headon M. Asymmetric diabetic retinopathy associated with Fuchs’ heterochromic cyclitis. Br J Ophthalmol. 1999;83(8):987-987.CrossRef
27.
Al Shehri FS. Uveitis in diabetic woman. International Journal of Diabetes Mellitus. 2009;1(1):59–60.CrossRef
28.
Guy R, et al. Diabetic autonomic neuropathy and iritis: an association suggesting an immunological cause. Br Med J (Clin Res Ed). 1984;289(6441):343–5.CrossRef
29.
Patel AK, et al. Risk of retinal neovascularization in cases of uveitis. Ophthalmology. 2016;123(3):646–54.CrossRefPubMed
30.
Joussen AM, et al. A central role for inflammation in the pathogenesis of diabetic retinopathy. FASEB J. 2004;18(12):1450–2.PubMed
31.
32.
Fujikawa LS, et al. Retinal vascular endothelium expresses fibronectin and class II histocompatibility complex antigens in experimental autoimmune uveitis. Cell Immunol. 1987;106(1):139–50.CrossRefPubMed
33.
34.
Ongkosuwito JV, et al. Analysis of immunoregulatory cytokines in ocular fluid samples from patients with uveitis. Invest Ophthalmol Vis Sci. 1998;39(13):2659–65.PubMed
35.
Nussenblatt RB, et al. The immunological basis of degenerative diseases of the eye. Int Rev Immunol. 2013;32(1):97–112.CrossRefPubMed
36.
Adamis AP, Berman AJ. Immunological mechanisms in the pathogenesis of diabetic retinopathy. Semin Immunopathol. 2008;30(2):65–84.CrossRefPubMed
37.
Cantón A, et al. CD4-CD8 and CD28 expression in t cells infiltrating the vitreous fluidin patients with proliferative diabetic retinopathy: a flow cytometric analysis. Arch Ophthalmol. 2004;122(5):743–9.CrossRefPubMed
38.
Demircan N, et al. Determination of vitreous interleukin-1 (IL-1) and tumour necrosis factor (TNF) levels in proliferative diabetic retinopathy. Eye (Lond). 2006;20(12):1366–9.CrossRef
39.
Elner SG, et al. Interferon-induced protein 10 and interleukin 8: CXC chemokines present in proliferative diabetic retinopathy. Arch Ophthalmol. 1998;116(12):1597–601.CrossRefPubMed
40.
Adamiec-Mroczek J, Oficjalska-Mlynczak J, Misiuk-Hojlo M. Roles of endothelin-1 and selected proinflammatory cytokines in the pathogenesis of proliferative diabetic retinopathy: Analysis of vitreous samples. Cytokine. 2010;49(3):269–74.CrossRefPubMed
41.
Murugeswari P, et al. Proinflammatory cytokines and angiogenic and anti-angiogenic factors in vitreous of patients with proliferative diabetic retinopathy and Eales’ disease. Retina. 2008;28(6):817–24.CrossRefPubMed
42.
Zhou J, Wang S, Xia X. Role of intravitreal inflammatory cytokines and angiogenic factors in proliferative diabetic retinopathy. Curr Eye Res. 2012;37(5):416–20.CrossRefPubMed
43.
Bromberg-White JL, et al. Identification of VEGF-independent cytokines in proliferative diabetic retinopathy vitreous. Invest Ophthalmol Vis Sci. 2013;54(10):6472–80.CrossRefPubMed
44.
Takeuchi M, et al. Elevated levels of cytokines associated with Th2 and Th17 cells in vitreous fluid of proliferative diabetic retinopathy patients. PLoS One. 2015;10(9):e0137358.CrossRefPubMedPubMedCentral
45.
Doganay S, et al. Comparison of serum NO, TNF-α, IL-1β, sIL-2R, IL-6 and IL-8 levels with grades of retinopathy in patients with diabetes mellitus. Eye. 2002;16(2):163–70.CrossRefPubMed
46.
Funatsu H, et al. Aqueous humor levels of cytokines are related to vitreous levels and progression of diabetic retinopathy in diabetic patients. Graefes Arch Clin Exp Ophthalmol. 2005;243(1):3–8.CrossRefPubMed
47.
Gerl VB, et al. Extensive deposits of complement C3d and C5b-9 in the choriocapillaris of eyes of patients with diabetic retinopathy. Invest Ophthalmol Vis Sci. 2002;43(4):1104–8.PubMed
48.
49.
Jandrasits K, Krepler K, Wedrich A. Aqueous flare and macular edema in eyes with diabetic retinopathy. Ophthalmologica. 2003;217(1):49–52.CrossRefPubMed
50.
Ino-ue M, et al. Laser flare intensity in diabetics: correlation with retinopathy and aqueous protein concentration. Br J Ophthalmol. 1994;78(9):694–7.CrossRefPubMedPubMedCentral
51.
Moriarty A, et al. Studies of the blood-aqueous barrier in diabetes mellitus. Am J Ophthalmol. 1994;117(6):768–71.CrossRefPubMed
52.
Nguyen N, Schönherr U, Küchle M. Aqueous flare and retinal capillary changes in eyes with diabetic retinopathy. Ophthalmologica. 1995;209(3):145–8.CrossRefPubMed
53.
Moriarty AP, et al. Breakdown of the blood-aqueous barrier after argon laser panretinal photocoagulation for proliferative diabetic retinopathy. Ophthalmology. 1996;103(5):833–8.CrossRefPubMed
54.
Baudouin C, et al. MHC class II antigen expression by ocular cells in proliferative diabetic retinopathy. Fundamental & clinical pharmacology. 1993;7(9):523–30.CrossRef
55.
Udoetuk JD, et al. Risk of corticosteroid-induced hyperglycemia requiring medical therapy among patients with inflammatory eye diseases. Ophthalmology. 2012;119(8):1569–74.CrossRefPubMedPubMedCentral
56.
Savin J. Diabetes mellitus, sarcoidosis,? necrobiosis lipoidica. Proceedings of the Royal Society of Medicine. 1969;62(4):350.PubMedPubMedCentral
57.
Gordon D, Browne B. Macular oedema with associated uveitis and cataract following presentation of type 1 diabetes mellitus in severe ketoacidosis. Diabet Med. 2000;17(4):326–8.CrossRefPubMed
58.
Yamamoto J, et al. Severe bilateral necrotising retinitis caused by toxoplasma gondii in a patient with systemic lupus erythematosus and diabetes mellitus. Br J Ophthalmol. 2003;87(5):651–2.CrossRefPubMedPubMedCentral
59.
Knol JA, et al. Rapid progression of diabetic retinopathy in eyes with posterior uveitis. Am J Ophthalmol. 2006;141(2):409–12.CrossRefPubMed
60.
Suzuki H, Isaka M, Suzuki S. Type 1 diabetes mellitus associated with Graves’ disease and Vogt-Koyanagi-Harada syndrome. Intern Med. 2008;47(13):1241–4.CrossRefPubMed
61.
Krifa F, et al. Uveitis responding on gluten free diet in a girl with celiac disease and diabetes mellitus type 1. Gastroenterol Clin Biol. 2010;34(4–5):319–20.CrossRefPubMed
62.
Talat L, et al. The influence of diabetes mellitus on the management and visual outcome of patients with uveitis. Acta Ophthalmol. 2014;92(4):e329–30.CrossRefPubMed
Metadata
Title
Intraocular Inflammation in Diabetic Populations
Authors
Wajiha J. Kheir
Huda A. Sheheitli
Rola N. Hamam
Publication date
01-10-2017
Publisher
Springer US
Published in
Current Diabetes Reports / Issue 10/2017
Print ISSN: 1534-4827
Electronic ISSN: 1539-0829
DOI
https://doi.org/10.1007/s11892-017-0910-3

Other articles of this Issue 10/2017

Current Diabetes Reports 10/2017 Go to the issue

Microvascular Complications—Retinopathy (JK Sun and PS Silva, Section Editors)

Diabetic Eye Screening: Knowledge and Perspectives from Providers and Patients

Microvascular Complications—Retinopathy (JK Sun and PS Silva, Section Editors)

Screening Intervals for Diabetic Retinopathy and Implications for Care

Pathogenesis of Type 1 Diabetes (A Pugliese, Section Editor)

The Role of Epigenetics in Type 1 Diabetes

Macrovascular Complications in Diabetes (VR Aroda and A Getaneh, Section Editors)

Cardiovascular and Mortality Risks in Migrant South Asians with Type 2 Diabetes: Are We Winning the Battle?

Diabetes and Pregnancy (M-F Hivert, Section Editor)

Application of One-Step IADPSG Versus Two-Step Diagnostic Criteria for Gestational Diabetes in the Real World: Impact on Health Services, Clinical Care, and Outcomes

Psychosocial Aspects (S Jaser, Section Editor)

Shared Dysregulation of Homeostatic Brain-Body Pathways in Depression and Type 2 Diabetes
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits